We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current BRKR market cap is 8.92B. The company's latest EPS is USD 2.8180 and P/E is 20.89.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 742.8M | 854.5M | 721.7M | 800.7M | 864.4M |
| Operating Income | 124.5M | 109.2M | 64.8M | 48.1M | 43.5M |
| Net Income | 88.1M | 205.5M | 50.9M | 7.6M | 40.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.07B | 1.99B | 2.42B | 2.53B | 2.96B |
| Operating Income | 300.9M | 250.4M | 412.8M | 432.7M | 442.6M |
| Net Income | 197.2M | 157.8M | 277.1M | 296.6M | 427.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.82B | 4.25B | 4.51B | 5.9B | 6.11B |
| Total Liabilities | 2.58B | 2.84B | 3.06B | 4.08B | 4.27B |
| Total Equity | 1.23B | 1.39B | 1.43B | 1.81B | 1.83B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.77B | 3.05B | 3.65B | 3.61B | 4.25B |
| Total Liabilities | 1.83B | 2.07B | 2.57B | 2.48B | 2.84B |
| Total Equity | 917.1M | 974.3M | 1.08B | 1.13B | 1.39B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 144.6M | 350.1M | 21.8M | 22.9M | 61.3M |
| Investing | -289.2M | -326M | -304.2M | -1.63B | -1.7B |
| Financing | -133.5M | -193.4M | 151.7M | 1.31B | 1.3B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 213.4M | 332.2M | 282.4M | 274.4M | 350.1M |
| Investing | -158.4M | -192.7M | -192.4M | -251.6M | -326M |
| Financing | 300M | -161.6M | 318.7M | -415.3M | -193.4M |
| Market Cap | 8.92B |
| Price to Earnings Ratio | 20.89 |
| Price to Sales Ratio | 3.01 |
| Price to Cash Ratio | 18.28 |
| Price to Book Ratio | 6.32 |
| Dividend Yield | 0.34% |
| Shares Outstanding | 151.6M |
| Average Volume (1 week) | 813.95k |
| Average Volume (1 Month) | 1.31M |
| 52 Week Change | -19.11% |
| 52 Week High | 94.86 |
| 52 Week Low | 48.07 |
| Spread (Intraday) | 0.86 (1.45%) |
| Company Name | Bruker Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bruker.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
